Browse > Article
http://dx.doi.org/10.4333/KPS.2005.35.4.279

Physicochemical Characterization and Dissolution Properties of CS-891 with Different Crystallinity  

Lee, Woo-Young (Pharmaceutical Development Labs, SamChunDang Pharma. Co., LTD.)
Park, Byoung-Woo (Pharmaceutical Development Labs, SamChunDang Pharma. Co., LTD.)
Park, Yong-Sun (Pharmaceutical Development Labs, SamChunDang Pharma. Co., LTD.)
Publication Information
Journal of Pharmaceutical Investigation / v.35, no.4, 2005 , pp. 279-285 More about this Journal
Abstract
Ground CS-891 (N-[1-(4-methoxyphenyl)-1-methylethyl]-3-oxo-4-aza-5a-androst-1-ene-$17{\beta}$-carboxamide) of poorly water soluble drug was obtained using a Heiko Seisakusho model TI-100 vibration mill, and samples with different crystallinity were prepared at mixture ratios of 10:0, 7:3, 5:5, 3:7 and 0:10 (intact;ground CS-891). Physicochemical characterizations were obtained using qualitative and quantitative X-ray diffractometry, different scanning calorimetry (DSC), scanning electron microscopy (SEM), Quantasorb surface area analyzer, and controlled atmosphere microbalance. With increase of amorphous CS-891 in mixture ratios, the intensities of X-ray diffraction peaks of crystalline CS-891 were decreased, whereas surface area, water absorption, and exothermic peaks in DSC were increased. The apparent solubility of ground CS-891 was $4.4\;{\mu}g/ml$ and the solubility of intact CS-891 was $3.1\;{\mu}g/ml$ at $37{\pm}1^{\circ}C$. The apparent precipitation rates of CS-891 in a supersaturated solution during the solubility test were increased with an increase of amorphous CS-891, and a crystalline form of CS-891 transformed from amorphous CS-891 after the solubility test was found by X-ray diffraction analysis, DSC and SEM. The dissolution profiles of CS-891 with different crystallinity at $37{\pm}1^{\circ}C$ by the USP paddle method were investigated, and the apparent dissolution rate constant of ground CS-891 was about 5.9-fold higher than that of intact CS-891. A linear relationships between the crystallinity of CS-891 and the apparent dissolution rate constant (r>0.96) were obtained.
Keywords
CS-891; Crystallinity; Dissolution rate; Solubility;
Citations & Related Records
연도 인용수 순위
  • Reference
1 K. Takeshima, N. Sunagawa, S. nagata, K. Hirano and Y. Takagishi, Effect of morphological properties on drug release from biodegradable microspheres, Yakugazu Zasshi, 112, 203-210 (1992)   DOI
2 Y. Nakai, K. Yamamoto, K. Terada and A. Kajiyama, Relationship between crystallinity of ${\beta}$-cyclodextrin and tablet characteristics, Chem. Pharm. Bull., 33, 5110-5112 (1985)   DOI   ScienceOn
3 Y. Nakai, K. Yamamoto and K. Terada, Crystallinity changes of ${\alpha}$- and ${\beta}$-cyclodextrins by grinding, Yakugaku Zasshi, 105, 580-585 (1985)   DOI
4 L.J.M. Tasic, M.D. Jovanovic and Z.R. Djuric, The influence of ${\beta}$-cyclodextrin on the solubility and dissolution rate of paracetamol solid dispersion, J. Pharm. Pharmacal., 44, 52-55 (1992)   DOI
5 M. Otsuka and N. Kaneniwa, Solubility of cephalexin crystals, Yakugaku Zasshi, 102, 967-971 (1982)   DOI
6 M. Otsuka, R. Teraoka and Y. Matsuda, Physicochemical properties of nitrofurantoin anhydrate and monohydrate and their dissolution, Chem. Pharm. Bull., 39, 2667-2670 (1991)   DOI
7 P.R. hermans and A. Weidinger, Quantitative X-ray investigation on the crystallinity of cellulose fiber a background analysis, J. Appl. Phys., 19, 491-506 (1948)   DOI
8 T. Higuchi, mechanism of sustained-action medication, J. Pharm. Sci., 52, 1145-1149 (1963)   DOI
9 M. Landin, R.M. Pacheco, J.L.G. Azoma, C. Souto, A. Concheiro and R.C. Rowe, Effect of country of origin on the properties of microcrystalline cellulose, Int. J. Pharmaceut., 91, 123-131 (1993)   DOI   ScienceOn
10 M. Morita, Y. Nakai, E. Fukuka and S. Nakajima, Physicochemical properties of crystalline lactose, Chem. Pharm. Bull., 32, 4076-4083 (1984)   DOI   ScienceOn
11 G.H. Rasmusson, G.F. Reynolds, T. Utne, R.B. Jobson, R.L. Primka, C. Berman and J.R Brooks, Azasteroids as inhibitor of rat prostatic 5${\alpha}$-reductase, J. Med. Chem., 27, 1690-1701 (1984)   DOI
12 P.K. Siiteri and J.D. Wilson, Dihydrotestosterone in prostatic hypertrophy, J. Clin. Invest., 49, 1737-1745 (1970)   DOI
13 Y. Nakai, K. Yamamoto, K. Terada and K. Akimoto, The dispersed states of medicinal molecules in ground mixtures with ${\alpha}$- and ${\beta}$-cyclodextrin, Chem. Pharm. Bull., 32, 685-691 (1984)   DOI
14 T. Yamaguchi, M. Nishimura, R. Okamoto, T. Takeuchi and K. Yamamoto, Glass formation of 4'-O-(4-methoxyphenyl) acetyltylosin and physicochemical stability of the amorphous solid, Int. J. Pharmaceut., 85, 87-96 (1992)   DOI   ScienceOn
15 T. Liang, M.A. Cascieri, A.H. Cheung, G.F. Reynolds and G.H. Rasmusson, Species differences in prostatic steroid 5${\alpha}$-reductases of rat, dog and human, Endocrinology, 117, 571-579 (1985)   DOI   ScienceOn
16 R. Brooks, C. Berman, R.L. Primka, G. Reynolds and G.H. Rasmusson, 5${\alpha}$-reductase inhibitory and antiandrogenic activities of some 4-azasteroids in the rat, Steroids, 47, 1-19 (1986)   DOI   ScienceOn
17 R.C. Rowe, A.G. mckillop and D. Bray, The effect of batch and source variation on the crystallinity of microcrystalline cellulose, Int. J. Pharmaceut., 101, 169-172 (1994)   DOI   ScienceOn
18 M.L. Shively and S. Myers, Solid-state emulsions; the effect of process and storage conditions, Pharm. Res., 10, 1071 (1993)   DOI   ScienceOn
19 S. Lowell, Continuous flow krypton adsorption for flow surface area measurements, Ana. Chem., 45, 1576-1577 (1973)   DOI